Novel imaging agents comprising caspase-3 inhibitors
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GE HEALTHCARE LTD
- Publication Date
- 2007-01-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
field of invention
[0001] The present invention relates to diagnostic imaging agents for in vivo imaging. Such imaging agents comprise synthetic caspase-3 inhibitors labeled with an imaging moiety suitable for in vivo diagnostic imaging. Background of the invention
[0002] Programmed cell death (apoptosis) is a complex process involving many cellular processes involving multilevel regulation. Apoptosis is initiated by one of two pathways. The first is an extrinsic pathway initiated by cell surface death receptors, and the second is an intrinsic pathway initiated by endogenous initiators such as DNA damage induced by UV radiation. These two pathways culminate in energy-demanding co-ordinated cell death, which, unlike necrotic cell death, does not involve an inflammatory response. Apoptotic cells send out "eat me" signals on their cell surface, which induce other cells to destroy them through phagocytosis.
[0003] Apoptosis is essential for many processes in the body. F...